United States Postoperative Nausea and Vomiting Management Market was valued at USD 0.8 Billion in 2022 and is projected to reach USD 1.3 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
Postoperative nausea and vomiting (PONV) is one of the most common and distressing complications faced by patients following surgery. In the United States, the management of PONV is a significant part of the healthcare system due to its widespread impact on patient recovery and overall hospital costs. With approximately 30% of surgical patients experiencing PONV, effective management strategies are crucial to enhance patient outcomes and reduce the burden on healthcare systems.
Several factors influence the occurrence of PONV, including the type of surgery, anesthesia used, and the patient's medical history. For instance, surgeries involving the abdomen, eye, or ear, nose, and throat (ENT) have higher incidences of PONV. Additionally, patients with a history of motion sickness, or those who have previously experienced nausea during anesthesia, are at a higher risk. This knowledge has led to more targeted approaches in managing PONV through pharmacological and non-pharmacological interventions.
Pharmacological treatments are a cornerstone in managing PONV. Drugs like serotonin antagonists (e.g., ondansetron), dopamine antagonists, and corticosteroids are commonly used to prevent and treat nausea and vomiting after surgery. Advances in these medications have resulted in better control of symptoms, allowing patients to recover more comfortably. The US postoperative nausea and vomiting management market has seen a rise in the development of more effective and less invasive medications, offering a wider range of treatment options for healthcare providers.
In addition to medications, non-pharmacological approaches such as acupuncture, acupressure, and ginger supplements have gained popularity. These alternatives are particularly appealing for patients who wish to avoid the side effects associated with medication. Integrating these methods into clinical practice has proven beneficial in reducing the need for pharmacological interventions and improving patient satisfaction.
Market trends indicate a growing demand for innovative solutions in the US postoperative nausea and vomiting management market. With technological advancements and increasing awareness of PONV's impact, both traditional and alternative treatments are evolving to meet patient needs. The market is expected to continue expanding as more surgical procedures are performed, and as hospitals strive to improve patient care and reduce recovery times.
Get an In-Depth Research Analysis of the US Postoperative Nausea and Vomiting Management Market Size And Forecast [2025-2032]
Acacia Pharma
Roche
Novartis AG
Ani Pharmaceuticals
Inc
Camurus AB
Sanofi S.A.
Helsinn Holding S.A.
Eisai Corporation
Merck and Co.
GlaxoSmithKline
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Postoperative Nausea and Vomiting Management Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Postoperative Nausea and Vomiting Management Market
5-HT3 Antagonists
NK1 Antagonists
Anticholinergic Drugs
Antihistamines
Others
Oral
Intravenous
Transdermal
Rectal
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Postoperative Nausea Management
Postoperative Vomiting Management
Serotonin Antagonists
Neurokinin Antagonists
Dopamine Antagonists
Others
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Postoperative Nausea and Vomiting Management Market Research Analysis
1. Introduction of the US Postoperative Nausea and Vomiting Management Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Postoperative Nausea and Vomiting Management Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Postoperative Nausea and Vomiting Management Market, By Type
6. US Postoperative Nausea and Vomiting Management Market, By Application
7. US Postoperative Nausea and Vomiting Management Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Postoperative Nausea and Vomiting Management Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/